137 related articles for article (PubMed ID: 7359154)
1. Monitoring fibrinolytic activity in the cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: a guide to the risk of rebleeding?
Maurice-Williams RS; Gordon YB; Sykes A
J Neurol Neurosurg Psychiatry; 1980 Feb; 43(2):175-81. PubMed ID: 7359154
[TBL] [Abstract][Full Text] [Related]
2. Source of fibrin/fibrinogen degradation products in the CSF after subarachnoid hemorrhage.
Vermeulen M; van Vliet HH; Lindsay KW; Hijdra A; van Gijn J
J Neurosurg; 1985 Oct; 63(4):573-7. PubMed ID: 3897478
[TBL] [Abstract][Full Text] [Related]
3. Determination of tranexamic acid (AMCA) and fibrin/fibrinogen degradation products in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage.
Fodstad H; Pilbrant A; Schannong M; Strömberg S
Acta Neurochir (Wien); 1981; 58(1-2):1-13. PubMed ID: 7282453
[TBL] [Abstract][Full Text] [Related]
4. Coagulation and fibrinolysis in blood and cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: effect of tranexamic acid (AMCA).
Fodstad H; Nilsson IM
Acta Neurochir (Wien); 1981; 56(1-2):25-38. PubMed ID: 7195642
[TBL] [Abstract][Full Text] [Related]
5. The fibrinolytic activity of cerebrospinal fluid after subarachnoid hemorrhage.
Steinmetz H; Grote E
Neurol Res; 1983; 5(4):59-65. PubMed ID: 6149487
[TBL] [Abstract][Full Text] [Related]
6. Fibrinolytic activity in blood and cerebrospinal fluid in subarachnoid hemorrhage from ruptured intracranial saccular aneurysm before and during EACA treatment.
Filizzolo F; D'angelo V; Collice M; Ferrara M; Donati MB; Porta M
Eur Neurol; 1978; 17(1):43-7. PubMed ID: 624294
[TBL] [Abstract][Full Text] [Related]
7. Tranexamic acid (AMCA) in aneurysmal subarachnoid haemorrhage.
Fodstad H
J Clin Pathol Suppl (R Coll Pathol); 1980; 14():68-73. PubMed ID: 7000850
[No Abstract] [Full Text] [Related]
8. Monitoring of fibrin and fibrinogen degradation products (FDP) in the cerebrospinal fluid of patients with subarachnoid haemorrhage due to ruptured aneurysm. Report of 55 cases.
Schisano G; Franco A; Nina P; Papa ML; Iannuzzi M; De Biase R; Caldora M
J Neurosurg Sci; 1994 Jun; 38(2):77-86. PubMed ID: 7891197
[TBL] [Abstract][Full Text] [Related]
9. [Role of local fibrinolytic activity on rebleeding of ruptured aneurysm (author's transl)].
Hashimoto T
Neurol Med Chir (Tokyo); 1978 Sep; 18(7 Pt 2):559-68. PubMed ID: 82219
[No Abstract] [Full Text] [Related]
10. Preoperative treatment of ruptured intracranial aneurysms with tranexamic acid and monitoring of fibrinolytic activity.
Alvarez Garijo JA; Vilches JJ; Aznar JA
J Neurosurg; 1980 Apr; 52(4):453-5. PubMed ID: 7373370
[TBL] [Abstract][Full Text] [Related]
11. Monitoring of antifibrinolytic therapy following subarachnoid hemorrhage. The importance of CSF fibrin/fibrinogen degradation products.
Sawaya R; Sonnino V; McLaurin RL; Perrotta G
J Neurosurg; 1983 May; 58(5):699-707. PubMed ID: 6834119
[TBL] [Abstract][Full Text] [Related]
12. Fibrinolytic activity after subarachnoid haemorrhage and the effect of tranexamic acid.
Tsementzis SA; Honan WP; Nightingale S; Hitchcock ER; Meyer CH
Acta Neurochir (Wien); 1990; 103(3-4):116-21. PubMed ID: 2205078
[TBL] [Abstract][Full Text] [Related]
13. [Fibrinolytic activity of cerebrospinal fluid in subarachnoid hemorrhage (author's transl)].
Imanaga H; Osugi T; Kagawa M; Kita-Mura K
No Shinkei Geka; 1977 Jan; 5(1):51-8. PubMed ID: 557178
[TBL] [Abstract][Full Text] [Related]
14. Prediction of cerebral vasospasm value of fibrinogen degradation products (FDP) in the cerebro-spinal fluid (CSF) for prediction of vasospasm following subarachnoid haemorrhage due to a ruptured aneurysm.
Guggiari M; Dagreou F; Rivierez M; Mottet P; Gallais S; Philippon J; Viars P
Acta Neurochir (Wien); 1984; 73(1-2):25-33. PubMed ID: 6496196
[TBL] [Abstract][Full Text] [Related]
15. Coagulation and fibrinolytic activity of cerebrospinal fluid.
Anderson M; Matthews KB; Stuart J
J Clin Pathol; 1978 May; 31(5):488-92. PubMed ID: 649775
[TBL] [Abstract][Full Text] [Related]
16. Fibrinolytic activity in the CSF and blood following subarachnoid haemorrhage.
Suzuki M; Kudo A; Otawara Y; Doi M; Kuroda K; Ogawa A
Acta Neurochir (Wien); 1997; 139(12):1152-4. PubMed ID: 9479421
[TBL] [Abstract][Full Text] [Related]
17. Fibrinolytic activity of cerebral tissue after experimental subarachnoid haemorrhage: inhibitory effect of tranexamic acid (AMCA).
Fodstad H; Kok P; Algers G
Acta Neurol Scand; 1981 Jul; 64(1):29-46. PubMed ID: 7198859
[TBL] [Abstract][Full Text] [Related]
18. [Fibrinolytic activity of cerebrospinal fluid as an indicator of the risk of repeated ruptures of arterial aneurysms].
Kholodov SA; Shelkovskiĭ VN; Platonova TK
Zh Vopr Neirokhir Im N N Burdenko; 1985; (4):18-22. PubMed ID: 4050242
[TBL] [Abstract][Full Text] [Related]
19. Effect of intraventricular haemorrhage and rebleeding following subarachnoid haemorrhage on CSF eicosanoids.
Pickard JD; Walker V; Brandt L; Zygmunt S; Smythe J
Acta Neurochir (Wien); 1994; 129(3-4):152-7. PubMed ID: 7847156
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic value of cerebrospinal fluid fibrinolytic activity in meningeal hemorrhages as a result of aneurysm rupture].
Rivierez M; Dagreou F; Guggiari M; Ankri A; Crespo B; Philippon J
Neurochirurgie; 1983; 29(2):119-23. PubMed ID: 6888630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
